Dr Chanda Kendra Ho

MD, MPH

Senior Consultant

Singapore General Hospital

Specialty: Gastroenterology ＆ Hepatology

Make an Appointment

About

Education and Training

Publications

Conditions Treated By This Doctor

Colorectal Cancer Screening Dyspepsia Fatty Liver Diseases Gastro-Oesophageal Reflux (GERD) Hepatitis B Hepatitis C Liver Cancer (Hepatocellular Carcinoma) Liver Cirrhosis Liver Transplant Metabolic Liver Disease

Clinical Interests

Transplant Hepatology

Clinical Appointments

Senior Consultant

Gastroenterology ＆ Hepatology

About

Dr. Ho is currently a Senior Consultant in the Department of Gastroenterology and Hepatology at Singapore General Hospital. Her clinical area of expertise is in transplant hepatology.

Dr. Ho completed her undergraduate studies at Harvard University. After medical school at the University of Tennessee, she was trained at Washington University in St. Louis/Barnes Jewish Hospital for internal medicine residency. She then completed both her gastroenterology and transplant hepatology fellowships at the University of California, San Francisco. Prior to joining SGH, Dr. Ho was Medical Director for Clinical Systems and Innovation at California Pacific Medical Center Department of Transplant and the Chief Innovation Officer for the transplant service line.

Dr. Ho is passionate about process and systems improvement and leveraging technology to improve patient outcomes and population health. She believes in a patient-centered approach in her practice and strongly advocates for her patients. She maintains board certifications in gastroenterology, transplant hepatology, and clinical informatics. Dr. Ho is active in the American Association for the Study of Liver Diseases.

Education and Training

Publications

Lee F, Ho C. Diagnosis and management of chronic hepatitis B: A patient-friendly summary of the 2018 American Association for the Study of Liver Diseases practice guidance. Clin Liver Dis (Hoboken). 2022 Nov;20(5):141-145.
Volk ML, Clarke C, Asrani SK, Khaderi S, Bansal MB, Tapper EB, Ho C, Chung RT, Lake J, Lim N, Fortune BE, Kim R, Dronamraju D, Kanwal F. Cirrhosis Quality Collaborative. Clin Gastroenterol Hepatol. 2022 May;20(5):970-972.
Asrani SK, Ghabril MS, Kuo A, Merriman RB, Morgan T, Parikh ND, Ovchinsky N, Kanwal F, Volk ML, Ho C, Serper M, Mehta S, Agopian V, Cabrera R, Chernyak V, El-Serag HB, Heimbach J, Ioannou GN, Kaplan D, Marrero J, Mehta N, Singal A, Salem R, Taddei T, Walling AM, Tapper EB. Quality measures in HCC care by the Practice Metrics Committee of the American Association for the Study of Liver Diseases. Hepatology.2022 May;75(5):1289-1299.
Ho C, Serper M. Practical Approach to Starting a Telemedicine Program: Lessons From the Real World. Clin Liver Dis (Hoboken). 2022 Apr;19(4):153-156.
Serper M, Parikh ND, Thiele G, Ovchinsky N, Mehta S, Kuo A, Ho C, Kanwal F, Volk M, Asrani SK, Ghabril MS, Lake JR, Merriman RB, Morgan TR, Tapper EB. Patient-reported outcomes in HCC: A scoping review by the Practice Metrics Committee of the American Association for the Study of Liver Diseases. Hepatology. 2022 Jul;76(1):251-274.
Sangaramoorthy M, Yang J, Guan A, DeRouen MC, Tana MM, Somsouk M, Thompson CA, Gibbons J, Ho C, Chu JN, Cheng I, Gomez SL, Shariff-Marco S. Asian American/Pacific Islander and Hispanic Ethnic Enclaves, Neighborhood Socioeconomic Status, and Hepatocellular Carcinoma Incidence in California: An Update. Cancer Epidemiol Biomarkers Prev. 2022 Feb;31(2):382-392.
Sangaramoorthy M, Yang J, DeRouen MC, Ho C, Somsouk M, Tana MM, Thompson CA, Gibbons J, Gomez SL, Shariff-Marco S. Disparities in Hepatocellular Carcinoma Incidence in California: An Update. Cancer Epidemiol Biomarkers Prev. 2020 Jan;29(1):79-87.
Singal AG, Rich NE, Mehta N, Branch A, Pillai A, Hoteit M, Volk M, Odewole M, Scaglione S, Guy J, Said A, Feld JJ, John BV, Frenette C, Mantry P, Rangnekar AS, Oloruntoba O, Leise M, Jou JH, Bhamidimarri KR, Kulik L, Tran T, Samant H, Dhanasekaran R, Duarte-Rojo A, Salgia R, Eswaran S, Jalal P, Flores A, Satapathy SK, Wong R, Huang A, Misra S, Schwartz M, Mitrani R, Nakka S, Noureddine W, Ho C, Konjeti VR, Dao A, Nelson K, Delarosa K, Rahim U, Mavuram M, Xie JJ, Murphy CC, Parikh ND. Direct-Acting Antiviral Therapy Not Associated With Recurrence of Hepatocellular Carcinoma in a Multicenter North American Cohort Study. Gastroenterology. 2019 May;156(6):1683-1692.e1.
Kanwal F, Tapper EB, Ho C, Asrani SK, Ovchinsky N, Poterucha J, Flores A, Ankoma-Sey V, Luxon B, Volk M. Development of Quality Measures in Cirrhosis by the Practice Metrics Committee of the American Association for the Study of Liver Diseases. Hepatology. 2019 Apr;69(4):1787-1797.
Tapper EB, Kanwal F, Asrani SK, Ho C, Ovchinsky N, Poterucha J, Flores A, Smith JE, Ankoma-Sey V, Luxon B, Volk ML. Patient-reported outcomes in cirrhosis: A scoping review of the literature. Hepatology. 2018 Jun;67(6):2375-2383.
Politi MC, George N, Li T, Korenblat KM, Fowler KJ, Ho C, Liapakis A, Roth D, Yee J. Project HELP: a study protocol to pilot test a shared decision-making tool about treatment options for patients with hepatitis C and chronic kidney disease. Pilot Feasibility Stud. 2018;4:55.
Gleason N, Prasad PA, Ackerman S, Ho C, Monacelli J, Wang M, Collado D, Gonzales R. Adoption and impact of an eConsult system in a fee-for-service setting. Healthc (Amst). 2017 Mar;5(1-2):40-45.
Ho CK, Boscardin CK, Gleason N, Collado D, Terdiman J, Terrault NA, Gonzales R. Optimizing the pre-referral workup for gastroenterology and hepatology specialty care: consensus using the Delphi method.J Eval Clin Pract. 2016 Feb;22(1):46-52.
Ho CK, Maselli JH, Terrault NA, Gonzales R. High Rate of Hospital Admissions Among Patients with Cirrhosis Seeking Care in US Emergency Departments. Dig Dis Sci. 2015 Jul;60(7):2183-9.
Ackerman SL, Gleason N, Monacelli J, Collado D, Wang M, Ho C, Catschegn-Pfab S, Gonzales R. When to repatriate? Clinicians' perspectives on the transfer of patient management from specialty to primary care.J Gen Intern Med. 2014 Oct;29(10):1355-61.
Ho C, Kornfield R, Vittinghoff E, Inadomi J, Yee H, Somsouk M. Late presentation of colorectal cancer in a vulnerable population. Am J Gastroenterol. 2013 Apr;108(4):466-70.
Manos MM, Ho CK, Murphy RC, Shvachko VA. Physical, social, and psychological consequences of treatment for hepatitis C : a community-based evaluation of patient-reported outcomes. Patient.2013;6(1):23-34.
Ho CK, Chapman WC, Brown DB. Radiofrequency ablation of recurrent hepatocellular carcinoma in a patient after liver transplantation: two-year follow-up. J Vasc Interv Radiol. 2007 Nov;18(11):1451-3.